overview
Asia’s pharma markets are extremely complex with each country governed by very different healthcare policies, reimbursement schemes, unique pricing, with large risks involved in entering the market, particularly with high priced, specialty drugs/therapeutics. Once way is to overcome this is to out-license, which cuts risks but can also decrease profits. There is also no guarantee that this will lead to success.
2nd Annual Pharma Market Access Asia 2018 brings pharma and industry together to navigate the complex environments and lessons learnt from successfully and profitable market entries for orphan drugs, high priced therapeutics, generics, biosimilars and more.
“Excellent event! Looking at multiple perspective from patients, policy maker, prescriber, provider, and payers. Well done to the producer and organizing team!”
Sebastien Boisseau, Market Access Director, Mundipharma
Snapshot of 2018 Attendee List:
Conference Highlights
- Country Case Studies – On market access by Pharma companies
- Growth Markets and Strategy Spotlight for Biosimilars, Generics, Orphan drugs, etc
- Pricing and Reimbursement – Strategies for improving market access
- Leveraging HEOR and RWE – In support of Market Access
- Out Licensing and Partnerships – For successful collaboration models
Choose your language
Part of
Co-Located Events
Accelerating Clinical Trials in Asia >>
Pharma Regulatory Affairs Asia >>
Pharma Market Access and Pricing Summit Asia >>
Digital Pharma Summit >>
Sponsorship
Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.
Partners
speakers

Danny Soon
Senior Director, Health and Biomedical Cluster, Biomedical Research Council (BMRC) A*STAR

Ho Weng Si
Director, Biomedical Sciences Group, Economic Development Board, Singapore

Kurt Scheinpflug
Senior Director of Digital Medicines Engineering, Proteus Digital Health, USA

Enver Erkan
Country Manager, Pfizer Singapore

Alexis Serlin
Asia Cluster Head, Novartis

Miguel Rivera
Global Digital Innovation Lead, Ferring Pharmaceuticals, Switzerland

How Ti-Hwei
Country President, AstraZeneca, Singapore

Jie Shen
Corporate Global Head of Pricing and Value Policy, Novartis, Switzerland

Jeff Weisel
Director, Life Sciences & Healthcare, Transaction Advisory Services, EY, Singapore

Gregory O’Toole
Reimbursement Strategy Specialist, AstraZeneca, Australia

Kathleen Yeoh
Director, Corporate Affairs and Market Access, ASEAN, Eli Lilly & Company, Malaysia

Cameron Milliner
Head of Public Affairs and Patient Advocacy - APAC, Shire, Singapore

Evelyn Pang
Head of Operations, Sanofi, Singapore

Sirinthip Petcharapiruch
Head of HEOR, Real-World Insights, IQVIA Asia Pacific

Yuki Sato
Representative Director, Deallus Consulting, Japan

Bruce Crawford
Vice President, Real-World & Late Phase, Syneos Health

Xingzhi Wang
Oncology HEOR Lead (Asia & Oceania), Astellas Pharma, Singapore

Min Su
Head of Health and Wellness Strategy Management, AIA International Limited, Hong Kong

Chan Wing Sze Cherry
Group Medical Advisor, AIA, Hong Kong

Yoshihiro Suwa
Partner, Head of Healthcare Southeast Asia, PT Roland Berger, Indonesia

Nathan Kothandaraman
Market Access & Government Affairs, Johnson & Johnson, Malaysia

Dr Tan Teck Jack
Group Managing Director and Chief Medical Officer, North East Medical Group, Singapore

Dr. Timothy Low
Board Director, Farrer Park Hospital, Singapore

Yu-Wen Huang
Senior Executive Officer, Medical Review and Pharmaceutical Benefits Division, National Health Insurance Administration, Ministry of Health and Welfare, Taiwan

Waranya Rattanavipapong
Head of International Unit, Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand

Neal Somchand
Principal, Deallus Consulting, Japan

Hang Le
APAC Regional Market Access Lead, Roche, Singapore

Manoj Saxena
Director Regional Market Access, Asia-Pacific, Bayer, Singapore

Mathew Thomas
Head, Public Affairs, Value Demonstration and Access - SEA, Shire, Singapore

Hazel Dy Tioco
Asia Pacific Regional Director, Study Management and Logistics, Sanofi, Philippines

Yaron Turpaz
Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore

Harish Dave
Co-Founder and Chief Medical Officer, Aum Biosciences, Singapore
when & where
19 - 20 Sep 2018
One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562
Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com
contact
Still have a question?
Customer Service
register@ibcasia.com.sg
+65 6508 2401
Speaking Opportunities
Siang Yee Yeo
+65-6508 2446
SiangYee.Yeo@ibcasia.com.sg
Sponsorship Opportunities
Yvonne Leong
+65 6508 2489
Yvonne.Leong@ibcasia.com.sg
Media & Association Partnership Opportunities
June Tan
+65 6508 2465
June.Tan@ibcasia.com.sg